Hi. We’re Noze.
how to smell.
Since 2015, we’ve been obsessed with a tricky problem that has life-changing potential: digital scent recognition. That obsession has led us to creating the world’s first commercially commercially ready digital nose. A huge deal for a space that’s been notorious for false starts and crushed hopes. We are now on a mission to elevate human health by unlocking the digital sense of smell, because we know this technology will change the world as we know it.
Adventures in digital olfaction.
THE SPARK
The story begins with the idea to digitize the sense of smell by leveraging recent technological advances in material science and artificial intelligence. The seed is planted.
HOUSTON, WE HAVE A PATENT
Learning that NASA Jet Propulsion Laboratory (JPL) had a technology that could push us forward, we went knocking. Soon after, we secured a worldwide exclusive license for the patents.
THE PROTOTYPE
We started building the first working version of our digital nose and almost immediately received orders for the prototype from two multinational companies on the other side of the world. It wasn't pretty. But it worked.
THE BLURRY PERIOD
We spent most of those two years with our heads down, just focusing on developing our technology. Was it intense? Oh yes. But we sure did get a lot done.
A PATENT OF OUR OWN
We were awarded our first patent by the United States Patent and Trademark Office for breaking new ground in chemical-sensing systems. For the curious types, it’s USPTO Patent #10386379B1.
RUNNING WITH THE BIG DOGS
Stratuscent (as Noze was called until 2022) was selected by BSH (formerly Bosch Siemens) to partner on developing a smart cooktop solution using the digital sense of smell. This has become an ongoing collaboration, and things are cooking nicely (literally as well as metaphorically).
ALL EYES ON NOZE
We took to the CES stage and showed the world the platform we’d been building over the last five years. That day, the digital nose made its way into the mainstream. You could say we officially stuck our Noze into everyone’s business.
ENTER COVID-19
The world suddenly came to a standstill, paralyzed by an airborne threat. Realizing that our technology could make a difference, we decided to focus all our efforts on releasing our indoor air quality (IAQ) scent library to allow people around the world to monitor the air within their homes to stay informed, healthy, and safe.
NEW NAME, NEW ERA
A long time ago, in a lab far, far away, we got obsessed with the idea of digitizing the sense of smell and using it to change the world. We were Stratuscent then. A lot has changed, and with a big series-A in our pocket and even bigger plans than before, we chose a bolder, punchier name to match our spirit — becoming Noze.
ALL-IN ON HEALTHCARE
Emerging from the COVID-19 pandemic and after witnessing the fragility of our healthcare systems, we saw a game-changing opportunity for our technology to reshape the healthcare landscape. Our mission crystallized: to pioneer a future characterized by the ubiquitous availability of point-of-care disease testing using the power of breath. We put our heads down, got to work… and DiagNoze was born.
The humans who make it possible.
Our growing team is a dynamic blend of trailblazers, thinkers, and innovators dedicated to revolutionizing healthcare diagnostics through digital olfaction. Meet our senior leadership team below!
.svg)
Mistral Ventures
Business Development Bank of Canada
noze
.svg)
Since founding the company in 2014, Dr. Ashok Masilamani has helped develop and secure patents for several groundbreaking inventions including the world’s first aroma monitoring application and the first digital olfaction-powered product—an AI-driven Air Intelligence Device. Ashok oversees the technology and engineering teams at Noze and leads the company’s efforts to revolutionize healthcare through the digital sense of smell. Prior to this, Ashok worked as a deep tech CTO at Applied Nanotools where he orchestrated the development and shipment of cutting-edge products like X-ray lenses and Silicon Photonics chips. He earned his Ph.D. from the University of Alberta and his Master of Engineering from the National University of Singapore. His undergraduate work was completed at the Madras Institute of Technology in India.
Karim is dedicated to driving the company's vision of revolutionizing healthcare by equipping clinicians with the transformative power of odor-based screening and diagnostics. Under Karim's leadership, Noze has transitioned seamlessly from the lab to clinical applications, achieving a remarkable fivefold expansion in scale, and successfully securing over $20 million in capital. Prior to Noze, Karim established one of the first startup studios in Canada in affiliation with one of the country’s largest universities. Karim holds an MBA from Insead in France, and graduated from Concordia University in Montreal with a degree in Finance.
Dr. Mojtaba Khomami Abadi is a recognized leader in the field of artificial intelligence, renowned for his pioneering work in emotion and personality recognition using smart watches and odor identification and quantification through artificial neural receptors. Mojtaba plays a key role in developing Noze’s proprietary machine intelligence solutions by spearheading efforts related to the understanding, design, and development of the information processing tools critical to the performance of Noze’s odor perception platform.
Dr. Jayan Ozhi Kandathil joined Noze in its early stages and played a pivotal role in bridging the gap between advanced research and practical applications. His achievements include transforming patented technology from NASA's Jet Propulsion Laboratory into an innovative healthcare product — a groundbreaking breath analyzer designed to screen for various health conditions.
Geoff Graham is the Director of Medical Devices at Noze. A leader in the field of healthcare technology and diagnostics, Geoff leads the Noze product team, which successfully created a prototype breath analyzer for early screening and diagnostics for use in clinical studies. Geoff and his team are now focused on integrating Noze's digital olfaction platform into medical devices ready for the market, which has the potential to revolutionize healthcare with early and accurate detection of health conditions through olfaction-based diagnostics.
Code has more than 25 years of experience as a company founder, operating executive and venture investor. He has invested in more than 50 technology companies across North America, and currently serves on the boards of several portfolio companies including Noze, Ceipal, Expeto, Soundpays, Symend, Edly and BlueJ Legal. He also serves as chairman of the board for the Ottawa International Airport Authority. Prior to Mistral, Code was the COO of Zephyr Technology (acquired by Covidien NYSE: COV), an investing Partner at Motorola Ventures and a Principal at Gabriel Venture Partners, both based in Silicon Valley. Code began his career as a radio frequency (RF) design engineer at IBM in Toronto Canada, and CIENA in Baltimore Maryland.
Business Development Bank of Canada
Joseph (Joe) Regan is the Senior Managing Partner for Venture Capital at BDC. With a venture career that spans over two decades, Joe brings deep venture capital expertise to the group. He joined BDC in 2019 from Export Development Canada, where he was head of the cleantech investment team and launched their internal seed investment fund. Previously, Joe was Founding Managing Partner at Bioenterprise, where he created the direction and strategy for an ag-tech venture fund positioned to accelerate agricultural and food-related innovation. Joe has directly invested over one hundred million dollars and served as a member of the Board of Directors of over thirty companies. Joe has an Honours B.Sc. from the University of Guelph and an MBA from McMaster University.
Since founding the company in 2014, Dr. Ashok Masilamani has helped develop and secure patents for several groundbreaking inventions including the world’s first aroma monitoring application and the first digital olfaction-powered product—an AI-driven Air Intelligence Device. Ashok oversees the technology and engineering teams at Noze and leads the company’s efforts to revolutionize healthcare through the digital sense of smell. Prior to this, Ashok worked as a deep tech CTO at Applied Nanotools where he orchestrated the development and shipment of cutting-edge products like X-ray lenses and Silicon Photonics chips. He earned his Ph.D. from the University of Alberta and his Master of Engineering from the National University of Singapore. His undergraduate work was completed at the Madras Institute of Technology in India.
Karim is dedicated to driving the company's vision of revolutionizing healthcare by equipping clinicians with the transformative power of odor-based screening and diagnostics. Under Karim's leadership, Noze has transitioned seamlessly from the lab to clinical applications, achieving a remarkable fivefold expansion in scale, and successfully securing over $20 million in capital. Prior to Noze, Karim established one of the first startup studios in Canada in affiliation with one of the country’s largest universities.
Dr. Mojtaba Khomami Abadi is a recognized leader in the field of artificial intelligence, renowned for his pioneering work in emotion and personality recognition using smart watches and odor identification and quantification through artificial neural receptors. Mojtaba plays a key role in developing Noze’s proprietary machine intelligence solutions by spearheading efforts related to the understanding, design, and development of the information processing tools critical to the performance of Noze’s odor perception platform.
Dr. Jayan Ozhi Kandathil joined Noze in its early stages and played a pivotal role in bridging the gap between advanced research and practical applications. His achievements include transforming patented technology from NASA's Jet Propulsion Laboratory into an innovative healthcare product — a groundbreaking breath analyzer designed to screen for various health conditions.
Geoff Graham is the Director of Medical Devices at Noze. A leader in the field of healthcare technology and diagnostics, Geoff leads the Noze product team, which successfully created a prototype breath analyzer for early screening and diagnostics for use in clinical studies. Geoff and his team are now focused on integrating Noze's digital olfaction platform into medical devices ready for the market, which has the potential to revolutionize healthcare with early and accurate detection of health conditions through olfaction-based diagnostics.
Let’s talk
Interested in learning more about one of our clinical studies? Got a question, or ten? Leave us your details below, and one of our experts will get in touch.
.svg)
.svg)
.svg)
.svg)
